Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May Executive Order 14297, titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Trump gave the companies 60 days to extend Most Favored Nation (MFN) pricing to all Medicaid patients, for newly launched drugs, to return increased revenues from negotiations with countries to American patients, and to provide for direct purchasing options to patients at MFN rates.

Full Article Available Here